Latest Breaking News On - Covishield india - Page 1 : comparemela.com

Mumbai: The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times. There s going to be an announcement in the next few days, Adar Poonawalla was quoted as saying by the newspaper in an interview published on Friday. Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July, later than a previous timeline of end-May. Several states in India have run out of vaccines against COVID-19.

United kingdomCity ofAdar poonawallaSerum instituteSerum institute of indiaCovishield indiaImage creditஒன்றுபட்டது கிஂக்டம்நகரம் ஆஃப்அடார் பூனாவல்லசீரம் நிறுவனம்சீரம் நிறுவனம் ஆஃப் இந்தியாபடம் கடன்